Valuation: Mesa Laboratories, Inc.

Market Cap 564M 490M 456M 419M 791M 53.85B 804M 5.38B 2.11B 26.81B 2.12B 2.07B 89.9B P/E 2027 *
74.1x
P/E 2028 * 47x
Enterprise Value 564M 490M 456M 419M 791M 53.85B 804M 5.38B 2.11B 26.81B 2.12B 2.07B 89.9B EV / Sales 2027 *
2.18x
EV / Sales 2028 * 2.07x
Free-Float
94.59%
Yield 2027 *
0.63%
Yield 2028 * 0.63%
1 day-0.23%
1 week+3.39%
1 month-3.43%
3 months-2.42%
6 months+28.00%
Current year+28.42%
1 week 95.75
Extreme 95.75
101.94
1 month 90
Extreme 90
106.04
Current year 71.06
Extreme 71.065
113.99
1 year 55.45
Extreme 55.45
113.99
3 years 55.45
Extreme 55.45
155.12
5 years 55.45
Extreme 55.45
333.42
10 years 55.45
Extreme 55.45
333.42
Manager TitleAgeSince
Chief Executive Officer 57 2026-04-11
Director of Finance/CFO 58 2012-10-28
Comptroller/Controller/Auditor 41 2021-12-31
Director TitleAgeSince
Chairman 73 2017-08-31
Director/Board Member 58 2019-03-03
Director/Board Member 57 2020-05-10
Date Insider Type Main position Quantity % Market Cap.
12/2/25 Don

Chairman

2,000 0.0362%
10/27/25 Fiscal year

Chief Executive Officer

11,558 0.2127%
8/18/25 Fiscal year

Director

7,708 0.1419%
Change 5-day change 1-year change 3-year change Capi.($)
-0.23%+3.39%+34.57%-20.84% 564M
+0.09%+2.56%-16.96%-4.37% 183B
-0.37%+2.62%-4.42%-2.61% 109B
-0.29%+0.47%+7.97%+64.64% 60.57B
+3.50%+0.47%+41.00%+46.44% 51.8B
+0.10%+5.92%-6.10%-40.54% 45.64B
+0.41%+1.37% - - 33.22B
+11.95%+16.65%+5.26%-31.60% 31.49B
+0.40%+3.89%+42.51%-8.26% 24B
-1.22%+6.69%+0.67%+1.96% 22.26B
Average +1.43%+4.71%+11.61%+0.54% 56.17B
Weighted average by Cap. +0.92%+3.49%-0.07%+4.21%

Financials

2027 *2028 *
Net sales 259M 225M 210M 193M 364M 24.74B 369M 2.47B 970M 12.32B 973M 952M 41.3B 272M 237M 220M 202M 382M 25.98B 388M 2.6B 1.02B 12.93B 1.02B 1B 43.37B
Net income 7.57M 6.58M 6.12M 5.62M 10.62M 722M 10.78M 72.17M 28.32M 360M 28.42M 27.79M 1.21B 12.13M 10.55M 9.82M 9.01M 17.02M 1.16B 17.29M 116M 45.42M 577M 45.57M 44.57M 1.93B
Net Debt - -
Logo Mesa Laboratories, Inc.
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical control solutions for regulated applications in the pharmaceutical, healthcare and medical device industries. The Company's segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, sells and services automated systems for protein analysis and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications, such as renal care, environmental and process monitoring.
Employees
717
Date Price Change Volume
26-07-31 $100.81 -0.23% 141,004
26-07-30 $101.04 +1.38% 90,860
26-07-29 $99.66 -1.42% 95,434
26-07-28 $101.10 +3.41% 112,556
26-07-27 $97.77 +0.28% 92,260
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
100.81USD
Average target price
112.00USD
Spread / Average Target
+11.10%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. MLAB Stock